ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Rakuten’s CEO raises $150M to fund his biotech outfit Aspyrian's cancer photoimmunotherapies
August 24, 2018Rakuten Aspyrian has raised $150 million in a series C round to fund its photoimmunotherapy platform and a phase 3 trial in head and neck cancer, alongside plans to expand its pipeline to include other tumor types, both as a monotherapy and in combination
Pharma Sources Insight January 2025
